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cade. Consequently, cAMP and EGF have great potential toCyclic AMP activates B-Raf and ERK in cyst epithelial cells
accelerate the progressive enlargement of renal cysts.from autosomal-dominant polycystic kidneys.
Background. The proliferation of mural epithelial cells is a
major cause of progressive cyst enlargement in autosomal-
dominant polycystic kidney disease (ADPKD). Adenosine 3,
Autosomal-dominant polycystic kidney disease5 cyclic monophosphate (cAMP) stimulates the proliferation
(ADPKD) is the most common monogenetic hereditaryof cells from ADPKD cysts, but not cells from normal human
kidney cortex (HKC), through the activation of protein kinase renal disorder in adults and is caused by the mutation
A (PKA), mitogen-activated protein kinase kinase (MEK), of PKD1 or PKD2 genes in most cases [1–3]. Fluid-
and extracellular signal-regulated kinase (ERK/MAPK). In the filled cysts derived from renal tubular epithelia are the
current study, we examined the signaling pathway between
hallmarks of ADPKD. Though not widely appreciated,PKA and MEK in ADPKD and HKC cells.
ADPKD is a neoplastic condition. The progressiveMethods. Primary cultures of human ADPKD and HKC
cells were prepared from nephrectomy specimens. We deter- expansion of kidneys is due to the accelerated prolifera-
mined the effects of cAMP and epidermal growth factor (EGF) tion of cells lining cyst cavities created by radial extension
on the activation of ERK, B-Raf and Raf-1 in ADPKD and of the mural epithelium in conjunction with the accumu-
HKC cells by immune kinase assay and Western blot.
lation of fluid within the expanding cysts [4]. AlthoughResults. 8-Br-cAMP increased phosphorylated ERK (2.7-
the initiation of cyst formation is controlled by genetic0.6-fold, N  7), and B-Raf kinase activity (3.6-  1.1-fold,
N 5) in cells from ADPKD kidneys; levels of phosphorylated events, the rate of cell proliferation within cysts is modu-
Raf-1 were not changed. Inhibition of PKA by H89 strikingly lated by external factors, including epidermal growth
decreased cAMP-stimulated phosphorylation of ERK and B-Raf, factor (EGF), together with hormones and autocoids
and MAPK inhibition by PD98059 blocked the effect of the
that activate adenylyl cyclase. Recently, adenosine 3, 5nucleotide to activate ERK. By contrast, in HKC cells 8-Br-
cyclic monophosphate (cAMP), an intracellular media-cAMP did not activate B-Raf and ERK. EGF stimulated the
phosphorylation of ERK and Raf-1 in both ADPKD and HKC tor of adenylyl cyclase agonists, was shown to stimulate
cells, but had no effect on B-Raf. 8-Br-cAMP and EGF con- the proliferation of cells derived from the cysts of human
jointly increased ERK activation above that of either agonist polycystic kidneys by activating the extracellular signal-
alone in ADPKD cells, and this combined effect was abolished
regulated kinase (ERK) [5].by PD98059, indicating that ERK was activated by EGF- and
ERK is the last of three serine-threonine kinases thatcAMP-responsive cascades that converge at MAPK.
Conclusion. cAMP activates ERK and increases prolifera- are serially activated in response to extracellular growth-
tion of ADPKD epithelial cells, but not cells from normal factor stimulation of the small GTPase protein, Ras.
human kidney cortex, through the sequential phosphorylation For example, EGF binding to receptor-tyrosine-kinaseof PKA, B-Raf and MAPK in a pathway separate from, but
activates Ras, which, in turn, directly phosphorylatescomplementary to, the classical receptor tyrosine kinase cas-
Raf-1 followed by sequential downstream activation of
mitogen-acitvated protein kinase kinase (MEK) and
1Tamio Yamaguchi and Shizuko Nagao contributed equally to this ERK. In several types of cells, including those from nor-
work. mal kidneys, cAMP inhibits this receptor-tyrosine-kinase
signaling pathway [6–10]. Thus, the mitogenic effect ofKey words: signal transduction, cellular proliferation, mitogen, MAPK,
Raf-1. cAMP we observed in concert with the activation of
ERK in ADPKD epithelial cells was unexpected [5]. InReceived for publication July 31, 2002
as much as the mammalian kidney is a target of numerousand in revised form December 9, 2002
Accepted for publication January 28, 2003 hormones (vasopressin, parathyroid hormone, secretin,
and vasoactive intestinal polypeptide), and autocoids 2003 by the International Society of Nephrology
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(prostaglandins and adenosine) that stimulate adenylyl ucts, Bedford, MA, USA) until the monolayers became
approximately 75% to 80% confluent. Cells were releasedcyclase to elevate intracellular levels of cAMP, the mo-
lecular mechanisms by which renal epithelial cells switch from the plastic with trypsin-ethylenediaminetetraacetic
acid (EDTA) solution, centrifuged, and the pellet rinsedfrom a nonmitogenic to a mitogenic response to the
nucleotide takes on added significance in a proliferative twice and resuspended in DMEM/F12 supplemented
with 5% FBS, penicillin/streptomycin and ITS.disorder such as ADPKD.
Cross talk between the cAMP and the MAPK signal-
Lectin staininging pathways in the regulation of cell proliferation has
been explored recently in cells from normal and cancer- ADPKD and HKC monolayers grown in 8-well cham-
ber slides were examined using two distal nephron specificous tissues [11]. The extent to which cAMP may inhibit
or stimulate cell proliferation appears to be highly cell- lectins, Arachis hypogaea (PNA) and Dolichos biflorus
agglutinin (DBA), and a proximal tubule lectin, Tetraglo-specific. For example, ERK is activated by cAMP in
neuronal cells, whereas phosphorylation and activation nolobus purpeas (LTA) [16–20]. The lectins were conju-
gated to horseradish peroxidase (HRP) and visualizedof this kinase is inhibited by cAMP in astrocytes [6].
The propensity of cAMP to stimulate or to inhibit ERK with 3, 3-diaminobenzidine (DAB). The concentration
of each lectin was 50 g/mL. Specificity of binding wasactivation may depend upon the relative abundance of
B-Raf, one of the three Raf proteins that act to transmit evaluated by preincubating the lectins with (200 mmol/L)
galactose (PNA), N-acetyl-galactosamine (DBA), or fu-extracellular-mediated signals [6–8]. B-Raf has a higher
affinity and a stronger stimulation toward MEK than cose (LTA), respectively.
A-Raf or C-Raf (Raf-1). Further in this regard, B-Raf
Intracellular cAMP measurementis differentially regulated by protein kinase A (PKA)
activation through Rap1 GTPase, which activates B-Raf Approximately 5  104 cells were seeded into individ-
ual chambers of a 12-well plate in DMEM/F12 containingbut not C-Raf [12, 13].
In the current study 8-Br-cAMP, a membrane perme- 1% FBS, ITS, and penicillin/streptomycin. At 75% to
80% confluence, ITS was deleted from the media andable analog of cAMP, was found to activate kinases ERK
and B-Raf in cyst-derived cells, but not in tubule cells the FBS was reduced to 0.002% to reduce cell growth.
After 24 hours, forskolin, desmopressin (DDAVP), pros-from normal human kidney cortex (HKC). Moreover,
EGF, which activates receptor tyrosine kinase, and cAMP taglandin E2 (PGE2), or EGF were added to the medium
for 15 minutes. Forskolin, PGE2, and EGF were pur-were found to have complementary effects on the activa-
tion of ERK and upon the stimulation of cell prolifera- chased from Sigma Chemical Co. (St. Louis, MO, USA)
and DDAVP from Rhone Poulenc Rorer Pharmaceuti-tion. It appears, therefore, that in renal tubules the phe-
notypic transformation from a normal to a cyst-forming cals (Collegeville, PA, USA). Intracellular cAMP was
extracted into 80% methanol, reconstituted in 0.05 mol/Lcell modifies the receptor-tyrosine-kinase and adenylyl
cyclase signaling pathways in such a way that their re- sodium acetate for quantitation using an enzyme-immu-
noassay system (Amersham Pharmacia Biotech, Buck-spective activation by different agonists would accelerate
the progressive enlargement of polycystic kidneys. inghamshire, UK). In a parallel set of culture plates, cell
protein content was measured by BCA Protein Assay
Kit (Pierce, Rockford, IL, USA). cAMP content was
METHODS
expressed in picomoles per milligram protein.
Cell culture
AntibodiesKidney cortex tissue was obtained from viable, al-
though discarded, nephrectomy specimens [ADPKD (five) Anti-ERK1 (C-16), anti-ERK2 (C-14), anti-phospho-
ERK (E-4), anti-B-Raf (C-19) and anti-Raf-1 (C-12) an-and normal (three), age 45 to 64 years old of either gender]
and placed in primary culture. The detailed methods have tibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), and anti-phospho-Raf-1 anti-been published previously [5, 14, 15]. The protocol for
retrieving surgically discarded kidney tissue was approved body was obtained from Upstate Biotechnology (Lake
Placid, NY, USA). Secondary antibodies, antirabbit,by the Human Subjects Committee at the University of
Kansas Medical Center. Cells from primary cultures antimouse, or antirat immunoglobulin G (IgG)-conju-
gated HRP antibodies were purchased from Santa Cruzwere stored in liquid nitrogen until they were thawed
and recultured in a flask containing Dulbecco’s modified Biotechnology.
Eagle’s medium/Ham F12 (DMEM/F12) supplemented
Western blot analysiswith 5% fetal bovine serum (FBS) (Hyclone, Logan, UT,
USA), 100 U/mL penicillin, 0.1 mg/mL streptomycin, Cells (105) were seeded in 100 mm diameter plastic
dishes containing DMEM/F12 with 5% FBS, ITS, andand 5 g/mL insulin, 5 g/mL transferrin, and 5 ng/mL
sodium selenite (ITS; Collaborative Biomedical Prod- penicillin/streptomycin. At 75% to 80% confluence, ITS
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was deleted and FBS was reduced to 0.002% for 24 ton, MA, USA) and 0.5 g of human MEK-1 fusion
protein (full-length, Santa Cruz Biotechnology)] at 30Chours. Then, 8-Br-cAMP (Sigma Chemical Co.) or EGF
were added for 15 minutes with or without 30 minutes for 30 minutes and stopped with SDS sample buffer.
Samples were heated (95C to 100C), beads were sedi-pretreatment with the PKA inhibitor, H89 (Calbiochem,
San Diego, CA, USA), or the MEK inhibitor, PD98059 mented and supernatant separated on 10% SDS-PAGE.
Activated B-Raf stimulated phosphorylation of MEK(New England Biolabs, Beverly, MA, USA). Cells were
lysed in 500 L of ice-cold Tris lysis buffer [TLB; 20 with radioactive (32P) that was detected by x-ray film and
quantified by Fluor-S MAX Multi Imager System.mmol/L Tris (pH 7.4), 137 mmol/L NaCl, 25 mmol/L
-glycerophosphate, 2 mmol/L EDTA, 1 mmol/L sodium
Statisticsorthovanadate, 2 mmol/L Na2HPO4, 1% Triton X-100,
10% glycerol, 1 mmol/L phenylmethylsulfonyl fluoride Mean and SEM were calculated, and levels of signifi-
cant difference (P  0.05) were determined by unpaired(PMSF), 5g/mL aprotinin, 5g/mL leupeptin, 2 mmol/L
benzamidine, and 0.5 mmol/L dithiothreitol]. Insoluble t test.
particles in the cell lysate were removed by centrifuga-
tion. Aliquots of soluble cellular protein were measured
RESULTS
by BCA Protein Assay Kit. Cell lysate (20 g protein)
Origin of cultured cellswas then heated (95C to 100C) in sodium dodecyl sul-
fate (SDS) sample buffer, separated by 10% SDS-poly- The cells used in this study were obtained from the
cortex of normal human kidneys and the epithelium lin-acrylamide gel electrophoresis (PAGE), and transferred
to nitrocellulose membrane (OPTITRANTM; Midwest ing the cavities of cysts on the surfaces of ADPKD kid-
neys. Cells from several cysts in a single kidney wereScientific, Valley Park, MO, USA). After transfer, the
membranes were blocked with 5% powdered milk in pooled together. HKC cells were obtained from cortical
tubule fragments of individual kidneys. The collagenaseTBS-T, pH 8.0 (20 mmol/L Tris-HCl, 137 mmol/L NaCl,
and 0.05% Tween 20) for 1 hour at room temperature digestion and other preparative steps were identical for
ADPKD and HKC.or overnight at 4C. Blocked membranes were incubated
with primary antibody in 5% powdered milk in TBS-T Cells cultured from both ADPKD and HKC sources
were epithelial, as demonstrated previously in our labo-for 2 hours at room temperature or overnight at 4C.
Membranes were then washed three times with TBS-T ratory [5, 15, 21]. Although the primary cultures of con-
fluent HKC and ADPKD cells derive from heteroge-and incubated with secondary antibody with 5% milk in
TBS-T for 1 hour. The membranes were washed three neous cells, they establish relatively tight junctional
complexes, and monolayers of them develop transmem-times with TBS-T, and proteins visualized using an en-
hanced chemiluminescence system (ECL; Amersham brane electrical potential differences and actively trans-
port salt and fluid [15, 21–23]. The cells comprising theLife Science, Arlington Heights, IL, USA). Intensity was
detected by x-ray film and blots were scanned and quanti- monolayers were typically pleomorphic (Fig. 1). They
stained with PNA and DBA, lectins that bind with hightatively analyzed by Fluor-S MAX Multi Imager System
(Bio-Rad, Hercules, CA, USA). affinity to distal convoluted and collecting tubule cells.
A majority of the HKC and ADPKD cells stained with
B-Raf kinase assay either PNA or DBA (Fig. 1 A and B) and this staining
was eliminated with the respective competing sugars,We modified the B-Raf kinase assay method by Er-
hardt et al [8]. This assay utilizes activated B-Raf, ob- galactose (Fig. 1D) or N-acetyl-galactosamine (Fig. 1E).
The heterogenous composition of the cultures was con-tained from cells, to phosphorylate exogenous MEK
substrate. Soluble cellular extract was obtained as de- firmed by the staining of a relatively few HKC and
ADPKD cells with LTA, a proximal tubule marker (Fig.scribed for the Western blot method. 500 g of soluble
cellular extract were immunoprecipitated for 2 hours 1C). This staining was eliminated with the competing
sugar, fucose (Fig. 1F).with gentle rotation at 4C with anti-B-Raf antibody
covalently coupled to protein A/G PLUS agarose beads
cAMP levels in ADPKD and HKC cells(Santa Cruz Biotechnology). Immunoprecipitates were
washed and resuspended in 20 L of [0.5 mmol -glycero- cAMP content was measured in cells from three
ADPKD kidneys (kidneys ## 136, 138, and 159) andphosphate (pH 7.3), 1.5 mmol ethylene glycol-bis (2-amino-
ethyl)-N, N, N’,N’-tetraacetic acid (EGTA), 1 mmol/L three kidneys from individuals without ADPKD (kid-
neys ## 129, 144, and 149). A maximally effective concen-dithiothreitol, 0.03% Brij 35]. The phosphorylation of
MEK was performed in reaction mixtures containing tration of forskolin (10mol/L) increased cellular cAMP
above control levels in ADPKD and HKC cells (Fig.20 L of kinase reaction solution [16 L of 50 mmol/L
MgCl2, 1L of 1 mmol ATP (Sigma Chemical Co.), 10 2). The difference between the forskolin responses of
ADPKD and HKC cells was not significant. The recep-Ci of 	-(32P)-ATP (6000 Ci/mmol, Perkin-Elmer, Bos-
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Fig. 1. Lectin staining of cells cultured from normal [human kidney cortex (HKC)] and autosomal-dominant polycycstic kidney disease (ADPKD)
kidney cortex. Confluent cultures on Transwell permeable supports. Upper Panel, HKC cells. (A ) HKC cells stained with Arachis hypogaea. (B )
HKC cells stained with Dolichos biflorus. (C ) HKC cells stained with Tetragonolobus purpeas. (D ) Arachis hypogaea plus 200 mmol/L galactose.
(E ) Dolichos biflorus plus 200 mmol/L N-acetyl galactosamine. (F ) Tetragonolobus purpeas plus 200 mmol/L fucose. Lower Panel, ADPKD cells.
(A ) ADPKD stained with Arachis hypogaea. (B ) ADPKD cells stained with Dolichos biflorus. (C ) ADPKD cells stained with Tetragonolobus
purpeas. (D ) Arachis hypogaea plus 200 mmol/L galactose. (E ) Dolichos biflorus plus 200 mmol/L N-acetyl galactosamine. (F ) Tetragonolobus
purpeas plus 200 mmol/L fucose. Magnification marker, 50 m.
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Fig. 2. Adenosine 3, 5 cyclic monophosphate (cAMP) levels in au-
tosomal-dominant polycystic kidney disease (ADPKD) () and human
kidney cortex (HKC) ( ) cells. Cells from three subjects with ADPKD
and three subjects with normal kidney cortex (HKC) were placed in
minimal growth media for 24 hours, and then agonists were added
for 15 minutes [forskolin, desmopressin (DDAVP), prostaglandin E2
(PGE2) and epidermal growth factor (EGF) or for 30 minutes [isobutyl-
methylxanthine (IBMX)]. cAMP content expressed in picomoles per
milligram protein. Optimum concentrations of agonists had been deter-
mined in preliminary experiments. Forskolin (10 mol/L); DDAVP
(100 mU/mL); PGE2 (25 ng/mL); IBMX (100mol/L); EGF (25 ng/mL);
H2O, solvent for DDAVP, PGE2, EGF, and IBMX; and ethanol (EtOH)
(0.1%), solvent for forskolin. The number of different kidneys is shown
in parenthesis. Bars represent means  SEM. *Difference from carrier
treated cells, P  0.05.
Fig. 3. Effect of 8-Br-cAMP on phosphorylated extracellular-regulated
kinase (P-ERK) levels in autosomal-dominant polycystic kidney disease
(ADPKD) cells. Cells from ADPKD kidneys were placed in minimal
growth media for 24 hours, and then 8-Br-cAMP (100 mol/L) wastor-mediated agonists DDAVP (100 mU/mL) and PGE2
added for 15 minutes with or without 30 minutes pretreatment with(25 ng/mL) also increased intracellular cAMP content H89 (10 mol/L) or PD98059 (50 mol/L). (A ) P-ERK intensity and
of ADPKD and HKC cells. Pretreatment with the phos- total ERK intensity in cells from two ADPKD kidneys. (B ) Relative
ERK activity (P-ERK intensity/total ERK intensity) compared withphodiesterase inhibitor, IBMX (100 mol/L), increased
control. Numerator in parenthesis is the number of determinations andthe cAMP content of cells in basal media, and increased the denominator is the number of different ADPKD kidneys. Bars
further the cAMP levels in response to forskolin, DDAVP, represent means  SEM. *Differences from control, P  0.05.
and PGE2 (data not shown). By contrast, EGF (25 ng/mL)
did not significantly increase intracellular cAMP content
nor did IBMX potentiate the response (data not shown).
ERK levels increased 267%  62% and P-ERK2/ERK2
ERK activation by cAMP in ADPKD cells levels increased 275%  65%, which were not different.
Pretreatment with the PKA inhibitor, H89 (10 mol/L),Utilizing an immune-kinase activity assay, we pre-
or the MEK inhibitor, PD98059 (50 mol/L), completelyviously demonstrated in cells from ADPKD kidneys
blocked the effect of 8-Br-cAMP to increase P-ERK(kidneys ## 136 and 138) that cAMP agonists stimulated
levels, indicating that the activation of this kinase wascellular proliferation and ERK phosphorylation [5]. In
PKA- and MEK-dependent.the current study, we quantified the activation of ERK
It is interesting to note that H89 and PD98059 de-in cells from these and three additional kidneys (kidneys
creased the basal levels of P-ERK to nearly undetectable## 158, 159, and 163) based on the intensity of phosphory-
levels. This observation suggests that in the control con-lated-ERK (P-ERK) expression in Western blots. Addition
dition the cells may have produced an autocrine factorof 8-Br-cAMP (100 mol/L) for 15 minutes confirmed
that stimulated the production of cAMP during the 24-the previous findings [5]. Figure 3A shows representa-
hour period in the growth-arrest medium. Preliminarytive blots from kidneys ## 138 and 159, whereas Figure
unpublished data from our laboratory suggest this may3B shows quantitative analysis from all five ADPKD
be due in part to the accumulation of small amounts ofkidneys in which P-ERK1 and P-ERK2 were determined
PGE2 and possibly adenosine, both of which can activatetogether. We also quantified the effect of 8-Br-cAMP on
the activation of ERK1 and ERK2, individually. P-ERK1/ adenylyl cyclase in these cells. On balance, these experi-
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Fig. 4. Time course of 8-Br-cAMP and epidermal growth factor (EGF)
effects on phosphorylated extracellular-regulated kinase (P-ERK) ex-
pression in human kidney cortex (HKC) and autosomal-dominant poly-
cystic kidney disease (ADPKD) cells. Cells from three HKC and two
ADPKD kidneys were placed in minimal growth media for 24 hours,
Fig. 5. Effect of 8-Br-cAMP on B-Raf activity in autosomal-dominantand then 8-Br-cAMP (100 mol/L) or EGF (25 ng/mL) were added.
polycystic kidney disease (ADPKD) cells. Cells from ADPKD kidneysLevels of activated ERK (P-ERK) were determined by Western blot
were placed in minimal growth media for 24 hours and 8-Br-cAMPat specified intervals. EGF transiently increased P-ERK in both HKC
(100 mol/L) was added for 15 minutes with or without 30 minutesand ADPKD. By contrast, 8-Br-cAMP increased P-ERK levels in
pretreatment with H89 (10 mol/L). (A ) B-Raf-activated (32P)-MEKADPKD cells for as long as 120 minutes, but had no effect on HKC.
and total B-Raf intensities in cells from three ADPKD kidneys. (B )
Relative B-Raf activity (B-Raf-activated (32P)-MEK intensity/total
B-Raf intensity) compared with control. Numerator in parenthesis is
the number of determinations, and the denominator is the number of
different ADPKD kidneys. Bars represent means SEM. *Differencesments show that cAMP activates ERK through PKA
from control, P  0.05.
and MEK-dependent mechanisms.
Time dependence of P-ERK activation response to
cAMP and EGF thereby blocking receptor-mediated activation of MEK
Experiments were performed in three HKC and two and ERK. However, recent studies have shown that
ADPKD cell lines to determine the time course of ERK cAMP can activate MEK and ERK in certain types of
phosphorylation induced by cAMP and EGF (Fig. 4). cells utilizing a Ras-independent pathway. In these cells
P-ERK levels of ADPKD cells were increased within 5 PKA leads to the activation of the serine-threonine-
minutes after adding 8-Br-cAMP to the medium and kinase B-Raf, which in turn activates MEK and ERK
remained elevated for 120 minutes. On the other hand, [11]. Thus, in cells enriched in B-Raf PKA may stimulate,
P-ERK levels remained low in HKC cells examined over rather than inhibit, MEK and ERK. We, therefore, em-
the same length of time. ployed an immune complex kinase assay using MEK as
P-ERK levels of both ADPKD and HKC cells were a substrate to determine B-Raf kinase activity after the
increased within 5 minutes after adding EGF to the me- addition of 8-Br-cAMP to the medium for 15 minutes
dium, but in contrast to cAMP, P-ERK levels returned (Fig. 5). In cells from all five ADPKD kidneys (three
to baseline after 60 minutes. These studies rule out the of them shown in Fig. 5A), 8-Br-cAMP (100 mol/L)
possibility that maximal rates of stimulation may have increased B-Raf phosphorylation of MEK substrate
occurred at different times after adding the agonists to 358%  114%, P  0.05. In the four kidneys that were
account for the difference responses of ADPKD and tested (kidneys ## 138, 158, 159, and 163), we found that
HKC cells to cAMP. the stimulatory effect on B-Raf activity was completely
blocked by pretreatment with 10 mol/L H89 (Fig. 5).
Effect of 8-Br-cAMP on B-Raf activation in B-Raf kinase activity was clearly increased by 8-Br-
ADPKD cells cAMP, and its striking inhibition by H89 indicated that
the effect of PKA induced by cAMP was a key factorIn the classical MAPK/ERK cascade leading to prolif-
eration, activation of Raf-1 by Ras leads to sequential in the activation process. On the basis of these observa-
tions, we conclude that the activation of ERK by cAMPphosphorylation of MEK and ERK [24]. Ordinarily, in-
creased levels of cAMP lead to inhibition of Raf-1, is mediated by B-Raf.
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Fig. 6. Effect of 8-Br-cAMP on phosphorylated extracellular-regulated
kinase (P-ERK) and B-Raf activity levels in human kidney cortex Fig. 7. Effect of 8-Br-cAMP on P-Raf-1 and Raf-1 levels in autosomal-
(HKC) cells. Cells from two HKC subjects were placed in minimal dominant polycystic kidney disease (ADPKD) and human kidney cor-
growth media for 24 hours and 8-Br-cAMP (100 mol/L) was added tex (HKC) cells. Cells from two ADPKD and two HKC kidneys were
for 15 minutes with or without 30 minutes pretreatment with H89 (10 placed in minimal growth media for 24 hours and 8-Br-cAMP (100
mol/L). The extent of ERK activation (P-ERK intensity/total ERK mol/L) was added for 15 minutes with or without 30 minutes pretreat-
intensity) and B-Raf activation (B-Raf activated (32P)-MEK intensity/ ment with H89 (10 mol/L). The intensity ratios of Raf-1 (P-Raf-1/
total B-Raf intensity) divided by the control ratio for each kinase is total Raf-1) compared with control are shown beneath each lane.
shown beneath each lane.
from two normal kidneys (Fig. 7). H89 (10 mol/L) did
It should be noted that, as for P-ERK expression (Fig. not affect the baseline activity of P-Raf-1 in either
3), H89 decreased basal B-Raf activity (Fig. 5), sug- ADPKD or HKC cells (Fig. 7). These findings indicate
that Raf-1 is not activated by PKA in either ADPKDgesting that B-Raf activity was dependent to some extent
or HKC cells.upon the endogenous activation of PKA.
EGF effect on Raf-1 and ERK in ADPKDEffect of 8-Br-cAMP on B-Raf and ERK activation in
and HKC cellsnoncystic HKC cells
Previously we showed that EGF stimulated the prolif-Previously, we found that cAMP did not increase the
eration of both ADPKD and HKC cells [5]. EGF (25
rate of cell proliferation or increase ERK activity in
ng/mL) activated ERK in both types of cells and this
epithelial cells obtained from normal kidney cortex [5]. effect was blocked by the MEK inhibitor, PD98059.
In the current study, we used one of the primary cultures In the current study, EGF increased the expression of
from the previous study (kidney # 129) and two addi- P-Raf-1 and P-ERK in cells from two ADPKD and two
tional normal kidney cortex culture preparations (kid- HKC kidneys, whereas the activity of B-Raf was not
neys ## 144 and 149) to explore the effect of cAMP on increased (Fig. 8A). In HKC cells, 8-Br-cAMP may have
Raf kinases. diminished the expression of P-Raf-1 slightly (Fig. 8B)
In contrast to ADPKD cells, 8-Br-cAMP (100mol/L) but H89 had no effect on EGF-stimulated P-Raf-1 ex-
did not increase the activity of ERK (88%  9% of pression (Fig. 8A). Although HKC did not respond to
cAMP by activating Raf-1, the cells were normally re-control) or B-Raf (99%  2% of control) in cells from
sponsive to activation by EGF. It appears, therefore,the three HKC kidneys lacking polycystin mutations
that Raf-1, but not B-Raf, is activated by EGF whereas(two of the blots are shown in Fig. 6). In cells from two
B-Raf, but not Raf-1, is activated by cAMP.subjects (kidneys ## 144 and 149), treatment with H89
(10mol/L) had no apparent effect on the baseline activ- Combined effects of EGF and cAMP on ERK activity
ity of either ERK or B-Raf (Fig. 6).
When forskolin, which activates adenylyl cyclase, and
EGF were added conjointly in our previous study, theEffect of 8-Br-cAMP on Raf-1 activation in ADPKD
rate of ADPKD cell proliferation increased greater thanand HKC cells
when either agonist was added alone [5]. By contrast,
We examined the effect of 8-Br-cAMP (100 mol/L) forskolin diminished the effect of EGF to stimulate pro-
on the activation of Raf-1 in both ADPKD and HKC liferation in HKC cells. In the current study, we exam-
cells. 8-Br-cAMP did not increase P-Raf-1 levels in cells ined the effect of 8-Br-cAMP and EGF on P-ERK ex-
from two ADPKD subjects, although it appeared to pression in comparison to the effects of each agonist
alone. In ADPKD cells, EGF and 8-Br-cAMP increasedslightly decrease the activation of this kinase in cells
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results are interpreted to indicate that the adenylyl cy-
clase and the receptor-tyrosine-kinase pathways con-
verge at MEK to activate ERK. By contrast, in HKC
cells the activation of ERK by EGF was not accentuated
by 8-Br-cAMP; rather, the nucleotide decreased the ex-
pression of P-ERK to a small extent (Fig. 9 E and F).
DISCUSSION
Renal tubule epithelial cells utilize intracellular
cAMP, generated by a host of endocrine and autocrine
agonists, to regulate an array of physiologic and patho-
physiologic functions. Under ordinary circumstances, the
day-to-day generation of renal epithelial cAMP is di-
rected primarily to the regulation of water and solute
transport, there being no effect of the nucleotide to stim-
ulate proliferation in these normally quiescent cells
[9, 10] (Fig. 10B). By contrast, in cyst-derived cells bear-
ing a mutated polycystin gene, cAMP is clearly mito-
genic, an aberrant behavior that appears to depend on
an alteration in B-Raf signaling [5, 25] (Fig. 10A).
In each ADPKD kidney used in this study, several
cortical cysts were used and presumably contained epi-
thelial cells that harbored both germ-line and somatic
mutations in polycystin-1 or polycystin-2 [26, 27]. By
contrast, it is reasonable to assume that cells derived
from normal kidneys had normal complements of poly-
cystins. Normal human cortex cells (HKC) may have
derived from proximal, distal and collecting tubules, and
glomeruli. Thus, is it possible that the qualitative differ-
ences in proliferation [5, 25] and ERK activation [5]
responses to cAMP of HKC and ADPKD cells could be
reflections of different types of progenitor cells that may
have been more abundant in one culture than in the
other. To address this issue we examined HKC and
ADPKD cells with lectin markers that preferentiallyFig. 8. Effect of epidermal growth factor (EGF) on Raf-1, B-Raf and
extracellular-regulated kinase (ERK) activity levels in autosomal-domi- stain distal convoluted and collecting tubules, or proxi-
nant polycystic kidney disease (ADPKD) and human kidney cortex
mal tubule cells [16–20]. A majority of the cells in the(HKC) cells. (A ) Cells from two ADPKD and two normal HKC were
placed in minimal growth media for 24 hours and EGF (25 ng/mL) was HKC and ADPKD cultures stained with distal nephron
added for 15 minutes with or without 30 minutes pretreatment with markers PNA and DBA (Fig. 1 A and B) suggesting
H89 (10 mol/L). P-Raf-1/Raf-1 intensity-, B-Raf-activated (32P)-MEK
that a significant fraction of the cells in the respectiveintensity/B-Raf- and P-ERK/ERK intensity ratios compared with con-
trol are shown beneath each lane. (B ) Cells from two ADPKD and cultures may have arisen from distal convoluted and
two normal HKC were placed in minimal growth media for 24 hours collecting tubules. Relatively few cells stained with theand 8-Br-cAMP (100 mol/L) or EGF (25 ng/mL) were added for 15
proximal tubule lectin marker, LTA (Fig. 1C). Whileminutes. The intensity ratios of Raf-1 (P-Raf-1/total Raf-1) compared
with control are shown beneath each lane. these studies do not prove that cultures of HKC and
ADPKD cells derive exclusively from distal nephron
segments, they establish that the cultures are similar in
respect to their lectin-binding profiles. Thus, it seemsP-ERK levels above that of either agonist alone (Fig. 9
unlikely that the clear-cut qualitative differences in theA and B). PD98059 completely blocked the effect of
proliferation and ERK-activation responses of HKC and8-Br-cAMP or EGF when administrated separately or in
ADPKD cells to cAMP can be ascribed to the predomi-combination. On the other hand, H89 had no effect on
nance of one progenitor cell type over another. Rather,the activation of ERK by EGF, although the PKA inhibi-
this phenotypic difference is most likely due to the facttor diminished P-ERK expression when EGF and 8-Br-
cAMP were added conjointly (Fig. 9 C and D). These that HKC cultures were derived from normal renal epi-
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Fig. 9. Combined effect of epidermal growth
factor (EGF) and adenosine 3, 5 cyclic mo-
nophosphate (cAMP) on phosphorylated ex-
tracellular-regulated kinase (P-ERK) expres-
sion in autosomal-dominant polycystic kidney
disease (ADPKD) and human kidney cortex
(HKC) cells. Cells from ADPKD and normal
HKC were placed in minimal growth media
for 24 hours and 8-Br-cAMP (100 mol/L) or
EGF (25 ng/mL) were added for 15 minutes
with or without 30 minutes pretreatment with
PD98059 (50 mol/L), or H89 (10 mol/L;
used only in ADPKD cells). (A ) Western blot
of P-ERK expression in cells from three
ADPKD kidneys and total ERK in cells from
one ADPKD kidney. (B ) Relative P-ERK
intensity compared with control. (C ) Western
blot of P-ERK in cells from three ADPKD
kidneys and total ERK in one kidney. 8-Br-
cAMP and EGF were added individually and
conjointly with or without H89 pretreatment.
(D ) Relative P-ERK activity compared to
control. (E ) Western blot of P-ERK in cells
from three HKC kidneys and total ERK in
cells from one HKC kidney. (F ) Relative
P-ERK intensity compared with control. Bars
represent means  SEM. *Differences from
control, P  0.05.
thelial cells and ADPKD cultures from mural cells lining collecting ducts [18, 28]. Thus, the primary cultures estab-
lished from cortical nephrons and cysts exhibit transportcysts.
It had previously been shown that cells in intact human processes indistinguishable from those found in collect-
ing ducts of the renal medulla, findings that further sup-ADPKD cysts react with distal nephron lectin markers
[17] as do cells cultured from normal human renal cortex port the view that the similar transport mechanisms ob-
served in the HKC and ADPKD monolayers reflect(HKC) [21]. Studies of electrolyte transport in polarized
monolayer cultures of ADPKD and HKC cells prepared dominance by cells with a common functional pheno-
type.in our laboratory indicate they are comprised of rela-
tively “tight” epithelia that have the capacity to generate ERK was activated by EGF in both ADPKD and
HKC cells, whereas cAMP activated ERK only insubstantial transepithelial electric potentials and short-
circuit currents [22, 23]. Net chloride secretion was stimu- ADPKD cells (Figs. 3 to 6, 8, 9). Thus, the consistency
of the mitogenic and ERK-activating responses to cAMPlated by cAMP in both cell lines, and, as shown in the
current study, HKC and ADPKD cultures generated in numerous ADPKD cell preparations and the lack of
an effect in HKC cells in this and preceding studiescAMP in response to several physiologic agonists. Re-
cent studies have established that cAMP stimulates chlo- suggests that the response to cAMP is most likely related
to changes imposed by cystic transformation, which af-ride and net fluid secretion in monolayers of cells cul-
tured from normal rat or human inner medullary fects all of the cells in the ADPKD cultures, rather than
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tion of MEK in ADPKD cells (Fig. 5), but there was no
discernible effect on the levels of phosphorylated Raf-1
(Figs. 7 and 8B). Since PD98059, a specific MEK inhibi-
tor, blocked the activation of ERK and decreased the
rate of cellular proliferation caused by cAMP [5], it
seems reasonable to conclude that B-Raf promotes MEK
activation in response to the cyclic nucleotide. The acti-
vation of ERK by B-Raf was completely inhibited by
the PKA inhibitor, H89, thus cAMP stimulates B-Raf
through the intermediate effect of activated PKA. Far
less likely is a role for PKA-independent mechanisms in
which cAMP directly activates Rap-1 or B-Raf via an
adaptor-like molecule [30].
It is interesting to consider that in the cAMP to ERK
pathway, small G proteins, such as Rap-1, may be inter-
posed between PKA and B-Raf. In many cells Rap-1
activates B-Raf through the intermediate action of Src
[31]. We have detected Rap-1 in ADPKD cells by West-
ern blot in preliminary studies and we have found in pre-
liminary studies that Src is activated by cAMP (T. Yama-
guchi, unpublished observations, 2002). Additional studies
are needed to further implicate these and other potential
intermediate proteins that may lie between the activation
of PKA by cAMP and the phosphorylation of B-Raf.
We have confirmed that EGF activation of the classical
receptor-tyrosine-kinase pathway leads to strong phos-
phorylation of Raf-1 and ERK in both ADPKD and
HKC cells (Fig. 8). Thus the proximal limb of the recep-
tor-tyrosine-kinase pathway extending to Raf-1 appears
to operate in a similar mode in both HKC and ADPKD
cells (Fig. 10). On the other hand, the Raf-1 and B-RafFig. 10. Signaling pathways in autosomal-dominant polycystic kidney
disease (ADPKD) and human kidney cortex (HKC) cells emphasizing kinases of normal and ADPKD cells appear to differ to
differences at the point of B-Raf and Raf-1 activation. (A ) ADPKD. a remarkable extent in the nature of their interactions
Adenylyl cyclase (AC) is stimulated by extracellular ligands, increasing
with PKA. cAMP did not increase the expression ofthe intracellular concentration of adenosine 3, 5 cyclic monophosphate
(cAMP) and the activation of protein kinase A (PKA). PKA, probably P-Raf-1 in HKC and ADPKD cells (Fig. 7), although the
through some intermediary steps remaining to be defined, activates nucleotide led to strong activation of B-Raf in ADPKD,
B-Raf, and thence MEK and extracellular-regulated kinase (ERK).
but not in HKC cells (Figs. 5 and 6). Interestingly, EGFEpidermal growth factor (EGF) activates receptor-tyrosine-kinase, Ras,
and Raf-1 to also phosphorylate MEK and ERK. (B ) Normal renal did not activate B-Raf kinase in either ADPKD or HKC
tubule cells. EGF activates Ras, Raf-1, MEK and ERK, as in ADPKD cells, suggesting that the pathway to ERK from Ras
cells, only in this case PKA inhibits EGF signaling to ERK and dimin-
through Raf-1 and MEK is reserved for agonists linkedishes cellular proliferation in response to growth factor stimulation.
to receptor-tyrosine-kinase activation (Fig. 10). Thus,
our studies indicate that EGF activates ERK through the
sequential stimulation of Ras, Raf-1 and MEK, whereas
selection of subpopulations of responsive or nonrespon- PKA activates ERK through its capacity to activate B-
sive cells. This view is supported further by our finding Raf and MEK (Fig. 10).
that the response of an immortalized culture of murine Yet this does not completely explain the complemen-
cortical collecting duct cells to cAMP could be switched tary actions of EGF and cAMP on ERK activation and
from a negative to a positive proliferative response to the relatively high rate of cell proliferation in ADPKD
cAMP by altering the function of polycystin-1 [29]. in contrast to normal cells [5] (Figs. 9 and 10). The simul-
The molecular basis of this phenotypic difference be- taneous addition of EGF and 8-Br-cAMP led to a strik-
tween normal and polycystic kidney cells is brought into ing increase in ERK activation, greater than either ago-
clearer focus by the current study. The capacity of cAMP nist alone (Fig. 9 A to D). Thus, in contrast to HKC
to provoke mitogenesis appeared to reside in the abnor- cells in which cAMP diminished the activation of Raf-1
mal susceptibility of B-Raf to activation (Figs. 5 and 6). and ERK, in ADPKD cells the nucleotide did not inhibit
the activation of Raf-1 by Ras. Thus, the phenotypiccAMP led to the activation of B-Raf and phosphoryla-
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response of ADPKD cells to cAMP reflects an increase sures to diminish the rate at which cysts enlarge in
ADPKD.in the sensitivity of B-Raf to activation by PKA as well
as relief from the inhibition of Raf-1 (Fig. 10).
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